Intellia Therapeutics Inc
NASDAQ:NTLA
Intellia Therapeutics Inc
NASDAQ:NTLA
Price:
13.3
USD
2.15%
Market Closed
Market Cap:
$1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
Baidu Inc
NASDAQ:BIDU
|
CN |
|
Total Energy Services Inc
TSX:TOT
|
CA |
|
Castile Resources Ltd
ASX:CST
|
AU |
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
JP |
|
N
|
Nissei Plastic Industrial Co Ltd
TSE:6293
|
JP |
|
Aviva PLC
OTC:AVVIY
|
UK |
|
U
|
United Overseas Bank Ltd
OTC:UOVEY
|
SG |
|
Turkcell Iletisim Hizmetleri AS
IST:TCELL.E
|
TR |
|
A
|
Aallon Group Oyj
OMXH:AALLON
|
FI |
|
Legal & General Group PLC
LSE:LGEN
|
UK |
|
Rimini Street Inc
NASDAQ:RMNI
|
US |
|
W
|
Westport Fuel Systems Inc
XBER:WPIA
|
CA |
|
Airbus SE
PAR:AIR
|
NL |
|
W
|
Woolworths Group Ltd
OTC:WOLWF
|
AU |
|
Lululemon Athletica Inc
NASDAQ:LULU
|
CA |
|
REA Group Ltd
ASX:REA
|
AU |
|
A
|
Akron PAO
LSE:AKRN
|
RU |
Multiples-Based Value
The Multiples-Based Value for Intellia Therapeutics Inc (NTLA) under the Base Case is hidden
USD.
Compared with the current market price of 13.3 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NTLA Multiples-Based Value
LOCKED
